Assessing the impact of direct-acting antivirals on hepatitis C complications: a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00210-023-02716-x.pdf
Reference46 articles.
1. American Association for the Study of Liver Diseases (2022). Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed 27 Feb 2023.
2. Baumert TF, Juhling F, Ono A, Hoshida Y (2017) Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals. BMC Med 15:52. https://doi.org/10.1186/s12916-017-0815-7
3. Butt AA, Yan P (2021) Natural history of hepatitis C virus infection in a large national seroconversion cohort in the direct-acting antiviral agent era: results from ERCHIVES. J Viral Hepat 28:916–924. https://doi.org/10.1111/jvh.13507
4. Cabibbo G, Celsa C, Calvaruso V et al (2019) Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. J Hepatol 71:265–273. https://doi.org/10.1016/j.jhep.2019.03.027
5. Carrat F, Fontaine H, Dorival C et al (2019) Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 393(10179):1453–1464. https://doi.org/10.1016/s0140-6736(18)32111-1
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan;Digestive Diseases and Sciences;2024-07-04
2. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan;2024-04-10
3. Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression;International Journal of Immunopathology and Pharmacology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3